---
layout: splash
title: 대웅제약 (069620)
excerpt: 대웅제약의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
keywords: 대웅제약, 069620
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 120,800 | <span style="color: tomato">0.3<small>%</small></span> | P:의약품 | 31.7 | 2.2 | 0.5<small>%</small> |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:의약품 / 의약품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 양약, 의료기기 제조/화장품, 의약부의품 도소매/부동산 임대 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 2002년 11월 1일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 전승호, 이창재 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.daewoong.co.kr](http://www.daewoong.co.kr){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 03&#x2011;21 | | [[기재정정]신규시설투자등              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240321801554){:target="_blank"} |
| 03&#x2011;20 | | [사업보고서 (2023.12)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240320001120){:target="_blank"} |
| 03&#x2011;14 | | [[기재정정]단일판매ㆍ공급계약체결              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240314802609){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![069620](/stock/images/069620.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 120,800 | <span style="color: tomato">0.3<small>%</small></span> | <span style="color: tomato">5.1<small>%</small></span> | <span style="color: tomato">4.1<small>%</small></span> | <span style="color: tomato">8.4<small>%</small></span> | <span style="color: tomato">12.6<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">14.7<small>%</small></span> | 31.4<small>%</small> | 0.47 | -20.0<small>%</small> | -6.2<small>%</small> | -0.7 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 31.7 | 2.2 | 0.5<small>%</small> | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/069620/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=069620){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A069620&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=069620){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/069620){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/069620/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![069620](/stock/images/069620_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 14.7<small>%</small> | 31.4<small>%</small> | 0.47 | -20.0<small>%</small> | -6.2<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 11.7<small>%</small> | 31.2<small>%</small> | 0.38 | -20.3<small>%</small> | -5.9<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -1.4<small>%</small> | 21.0<small>%</small> | -0.07 | -20.1<small>%</small> | -8.6<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 12.0<small>%</small> | 19.9<small>%</small> | 0.60 | -8.7<small>%</small> | -3.6<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -17.1<small>%</small> | 20.3<small>%</small> | -0.84 | -23.5<small>%</small> | -13.1<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -17.9<small>%</small> | 20.1<small>%</small> | -0.89 | -20.5<small>%</small> | -9.2<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -8.4<small>%</small> | 18.4<small>%</small> | -0.46 | -20.5<small>%</small> | -8.2<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 5.7<small>%</small> | 13.4<small>%</small> | 0.43 | -7.7<small>%</small> | -0.8<small>%</small> |
| MACD[^fn_tech_metric_macd] | -0.0<small>%</small> | 20.8<small>%</small> | -0.00 | -17.5<small>%</small> | -7.4<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![069620](/stock/images/069620_corr.png){: .align-center}

|       | [녹십자홀딩스](/005250/) | [레고켐바이오](/141080/) | [HLB](/028300/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [대웅](/003090/) | [한미약품](/128940/) | [CJ대한통운](/000120/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![069620](/stock/images/069620_2x.png){: .align-center}


> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}